New Gene Therapy Trial Targets Most Common Deafness Gene

Scientists have begun testing a breakthrough gene therapy that could restore hearing for people with the most common genetic cause of deafness.

Skylark Bio just dosed their first patient, marking a major step toward helping millions born with this genetic mutation.